Search Results

Keywords: synthetic

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.

Read More

Green is the New Black

Cutting energy and water use while adhering to sustainable growing practices can keep you competitive and help your bottom line By Omar Sacirbey OutCo, a cannabis cultivation, manufacturing and retail business headquartered in San Diego County, California, marked a milestone May 7: The company harvested its final crop grown under high-pressure sodium lights. It took […]

Read More

Movers and Shakers: A look at some recent hiring moves in the marijuana industry

By Omar Sacirbey Cannabinoid Drug Developer Lands Star Scientist Nemus Bioscience, a biopharmaceutical company in Costa Mesa, California, that develops cannabinoid-based medicines, tapped professor David Schubert, head of the Cellular Neurobiology Laboratory at California’s Salk Institute, as a consultant. Schubert, a two-time recipient of the Jacob Javits Award for outstanding contributions to neuroscience from the […]

Read More

Measure legalizing CBD medicine awaits OK from Colorado governor

The Colorado Legislature passed a bill that permits doctors to prescribe CBD medicines provided they have won approval from the U.S. Food and Drug Administration – a development that could happen within a matter of weeks. The state Senate signed off on the measure Tuesday, and it now moves to Gov. John Hicklenlooper for his signature. Passage […]

Read More

Impending ruling on epilepsy drug has CBD industry on alert

The most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers. GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval as legal medicine. The decision on […]

Read More

Hemp company launches first cannabis line aimed at minorities

A North Carolina company is making the cannabis industry’s first play for consumers of color with a line of beauty products aimed at ethnic minorities. The Hemp Excellence line of body lotions, lip balms and CBD capsules went on sale this month at two beauty shops that cater to women of color in Winston-Salem, North Carolina. […]

Read More

‘Launchpad to Asia’: Cronos pulls veil off Australian joint venture

Cronos Group unveiled its Australian joint venture and the first phase of a 10-million-Australian-dollar ($8 million) production facility, the latest move by a Canadian company to carve out opportunities to meet demand Down Under and position itself to capitalize on future possibilities in Asia. It’s the first Canadian company to help build a medical cannabis company in Australia […]

Read More

Surf and Turf

Cultivators shun synthetic nutrients in favor of organic mixes and soils, using worm excrement, alfalfa, lobster shells and more By Omar Sacirbey When Mark Simpkins moved from Austin, Texas, to southern Oregon a few years ago, his lack of cultivation experience may have been his greatest asset. Why? He never learned to grow marijuana using […]

Read More

CBD is no longer taboo, says global anti-doping regulator

CBD will take another big step toward the mainstream next year when the World Anti-Doping Agency (WADA) removes hemp-based products from a list of banned substances. WADA’s 2018 listing will show that “cannabidiol is no longer prohibited,” though the agency didn’t explain why CBD was removed. WADA – whose mission is to combat illicit drugs […]

Read More

Tuatara invests $3.3 million in Colorado cannabis extracts firm

Tuatara Capital, a New York-based canna-centric investment private equity fund, has invested $3.3 million in marijuana extracts company Green Dot Labs. Boulder, Colorado-based Green Dot Labs initially had sought to raise $2.6 million in its Series A round, but Tuatara supplied all of the funding – and then some – a spokeswoman for the extracts […]

Read More